enVVeno Medical Corporation (NVNO) Stock Forecast
NVNO analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 5.00 / 5 from 1 analysts
- Price target
- $30.00 average of analyst targets
- Upside to target
- +301.6% from the latest close
- Next earnings
- October 30, 2026
- 52-week range
- $7.40 – $27.02
NVNO analyst ratings
1 analystsNumber of analysts at each rating.
NVNO price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NVNO earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$3.27 | −$3.27 | −$3.27 | — | — | 1 |
| Current fiscal year (2026) | −$16.19 | −$16.19 | −$16.19 | — | — | 1 |
| Next fiscal year (2027) | −$6.22 | −$6.22 | −$6.22 | −$16.19 | +61.6% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NVNO revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0 | $0 | $0 | — | 1 |
| Current fiscal year (2026) | $0 | $0 | $0 | — | 1 |
| Next fiscal year (2027) | $0 | $0 | $0 | 0.0% | 1 |
NVNO EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NVNO EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.00 | $0.00 | $0.00 | $0.00 | −$3.27 | — | 0 up · 1 down |
| Current fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | −$16.19 | — | 0 up · 1 down |
| Next fiscal year (2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$6.22 | — | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NVNO earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NVNO beat in 8 of 12.
What analysts expect from NVNO
1 analysts cover enVVeno Medical; their consensus rating is strong buy (5.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $30.00, 301.6% above the latest close of $7.47. Analysts expect earnings of −$16.19 per share for 2026. For 2027 the average estimate is −$6.22 per share. enVVeno Medical beat the EPS estimate in 8 of the last 12 quarters.
Related: NVNO income statement, NVNO key metrics, NVNO chart. See the NVNO stock overview for the latest quote and news.
NVNO forecast FAQ
What is enVVeno Medical's price target?
The average analyst price target for enVVeno Medical is $30.00, 301.6% above the latest close of $7.47.
Is enVVeno Medical a buy, hold or sell?
Of 1 analysts covering enVVeno Medical, 1 rate it a strong buy, 0 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is enVVeno Medical's EPS forecast?
Analysts forecast −$16.19 per share for 2026 (range −$16.19 to −$16.19); for 2027 the estimate is −$6.22.
When does enVVeno Medical report earnings?
enVVeno Medical is expected to report results for the quarter ending September 30, 2026 on October 30, 2026.
Does enVVeno Medical usually beat earnings estimates?
enVVeno Medical reported EPS at or above the analyst estimate in 8 of the last 12 quarters.